Surgical Science Sweden AB (publ) (OTCMKTS:SUSRF) Stock Price Down 6.1% – What’s Next?

Surgical Science Sweden AB (publ) (OTCMKTS:SUSRF)’s share price fell 6.1% on Monday . The company traded as low as $3.41 and last traded at $3.41. 1,000 shares traded hands during mid-day trading, a decline of 72% from the average session volume of 3,524 shares. The stock had previously closed at $3.63.

Wall Street Analysts Forecast Growth

Separately, Pareto Securities downgraded shares of Surgical Science Sweden AB (publ) to a “hold” rating in a report on Wednesday, November 26th. One investment analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the stock presently has an average rating of “Hold”.

Surgical Science Sweden AB (publ) Stock Down 6.1%

The company has a 50 day moving average price of $6.00 and a 200-day moving average price of $9.98.

Surgical Science Sweden AB (publ) Company Profile

Surgical Science Sweden AB (publ) develops and markets virtual reality–based medical simulation solutions designed to train healthcare professionals in minimally invasive surgical techniques. Headquartered in Gothenburg, Sweden, the company leverages advanced haptic feedback and three-dimensional graphics to create realistic, interactive scenarios for a range of surgical disciplines, including laparoscopy, endoscopy and arthroscopy. Its platform allows trainees to practice complex procedures in a risk-free environment, helping to improve precision and reduce the learning curve for both trainees and experienced practitioners adapting to new technologies.

The company’s product portfolio includes LapSim for basic and advanced laparoscopic skills, EndoSim for gastrointestinal endoscopy, ArthroSim for diagnostic and therapeutic arthroscopy, as well as modules for vascular and bronchial interventions.